The Times of India reports that India’s National Centre for Disease Control is initiating a study intended to assess the prevalence of Carbapenem (a class of antibiotics) resistance within hospital settings and in the environment. The sixth month-long study is scheduled to begin in May. It will examine all intensive care unit admissions in three New Delhi-based hospitals. Additional hospitals outside New Delhi might also participate in the study. In addition, water samples will be taken from the environment surrounding the hospitals and tested for drug-resistant bacteria. Initiation of this study suggests a shift in India’s policy response to the detection of NDM-1 in clinical settings and local water supplies.